INTS6 antisense RNA 1 (INTS6-AS1)

INTS6 antisense RNA 1 (INTS6-AS1) is a human long non-coding RNA transcribed from the INTS6 gene locus on chromosome 13 (13q14). It belongs to the class of natural antisense transcripts and acts, alongside other lncRNAs, as a regulator of gene expression via effects on transcription, splicing, and chromatin architecture[4][5][6][1]. Dysregulation of NATs, such as INTS6-AS1, has been implicated in several diseases, particularly cancer, where aberrant expression can silence tumor suppressor genes and modulate alternative splicing. INTS6-AS1’s molecular function is still being elucidated, but it is predicted to play a role in cotranslational protein targeting to membranes and signal sequence recognition[9]. No therapeutic drugs currently target INTS6-AS1, but related antisense transcripts are under investigation for antisense oligonucleotide therapies[1]. This target is best categorized as a long non-coding RNA regulator rather than a classical receptor, enzyme, or transporter. Its function and disease involvement are mainly inferred from its general molecular class and associated gene locus, with specific details on its biological role and therapeutic potential still under investigation[1][5][9].

Other names

INTS6-AS1INTS6 antisense RNA 1 (non-protein coding)INTS6-AS1 RNA

Antisense oligonucleotides (ASOs) may silence target RNAs via RNase H-mediated degradation, altering splicing, or modulating translation